T Cell Receptor Depletion in Stem Cell Transplant
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 48 patients (estimated)
- Sponsors
- University of Minnesota - Masonic Cancer Center
- Tags
- Adoptive Cellular Therapy, Chemotherapy, Monoclonal Antibody, T Cell (Allogeneic), CD20, Radiation Therapy, Steroid
- Trial Type
- Treatment
- Last Update
- 2 weeks ago
- SparkCures ID
- 1579
- NCT Identifier
- NCT03579875
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.